Leave a comment

Updated information about the mission to Japan (Oct. 9th – 14th, 2016)

The European Strategic Cluster Partnership alliance on Personalized Healthcare, bioXclusters plus, gathering 4 European BioClusters – BiocatBioMBioPmed and Lyonbiopole –, have organized a trade mission that will be heading to Japan this month.

This mission is organized in coordination with the EU-Japan Centre, that offers a “Biotech Cluster SME Mission” from Oct 9th to 14th 2016.

The program includes workshops about Japanese life science market and regulation (10th October). A cultural visit is also planned to deeply dive into the Japanese values and history.

Continue reading


Leave a comment

European and Australian organisations sign international super cluster agreement

Six organisations representing life sciences and health clusters in Europe and Australia have signed a business development agreement today at BIO International Convention 2016 in San Francisco.

The agreement will help fast-track business results for companies and solve a common problem for small-to-medium enterprises (SMEs) – landing in new markets.

The organisations are from five regions: Adelaide (Australia), Catalonia (Spain), Auvergne-Rhone Alpes Region (France), Bavaria (Germany) and Piedmont (Italy).

Continue reading


1 Comment

Announcement of the mission to Japan (Oct. 9th – 14th, 2016)

The European Strategic Cluster Partnership alliance on Personalized Healthcare, bioXclusters+, gathering 4 European BioClusters – Biocat, BioM, BioPmed and Lyonbiopole – is glad to invite European SMEs based in the 4 bioXclusters+ regions to join the mission organized in the framework of BioJapan (Oct. 12 to 14, 2016).

This mission is organized in coordination with the EU-Japan Centre, that offers a “Biotech Cluster SME Mission” from Oct 10th to 14th 2016. Thus, European Clusters and SMEs, that are not partner of the bioXclusters+ alliance (see the details with bioXclusters+ regional contacts) and willing to join these missions are invited to apply through the EU-Japan Centre (deadline for submission: June 9th, 2016). Find all the details here: http://www.eu-japan.eu/events/biotech-cluster-sme-mission Continue reading


Leave a comment

The European Commission renews its support to the bioXclusters Alliance, “the European Strategic Cluster Partnership on Personalised Healthcare”

The European meta-cluster project bioXclusters plus (European Strategic Cluster Partnership on Personalised Healthcare) has been selected by the European Commission Executive Agency for Small and Medium-sized Entreprises (EASME) for the call for proposals COS-CLUSTER-2014-3-03 – Cluster Going International. Continue reading


Leave a comment

EU-Japan Cluster Matchmaking Event at BioEurope Report

The “EU‐Japan Cluster Matchmaking Event” was held at BIO‐Europe in Frankfurt, Germany, on November 3rd, 2014. Leading Japanese health care cluster representatives and their European counterparts met to build first bridges between their organisations in order to path the way for potential collaborations – and long-term to support SMEs to find business partners.

EU-Japan Foto Four key regions plus The Japan Bioindustry Association (JBA) outlined the vast array of opportunities that the Japanese pharma and health market offers to Europe. 30 attendees took also the advantage of exchanging business contacts and to meet people offering to help with building valuable connections in the otherwise difficult to approach Japanese market.

It is planned to follow up with a 2nd EU-Japan Cluster Matchmaking Event at BIO-Europe 2015 in Munich.

Report – EU-Japan matchmaking event


Leave a comment

EU-Japan Cluster Matchmaking Even at BioEurope – 3rd November 2014

The EU‐Japan Cluster Matchmaking Event – financially supported by the European Commission (http://www.clustercollaboration.eu) – is taking place at Bio Europe in Frankfurt (Germany) on November, 3rd. It provides the perfect opportunity to gain an overview of the strengths of the Japanese life sciences landscapes and clusters in the health care sector.

Speakers from four leading Japanese life science clusters and from Japan Bioindustry Association (JBA) will present the vast array of opportunities that the Japanese pharma and health market offers to European companies.

If you work for a European life science cluster or if you are a manager of a company that targets the Japanese market, do not miss the opportunity to establish valuable contacts at this event. It creates the basis for cluster cooperations, R&D projects, licensing opportunities, attracting joint partnerships, developing small scale, high value manufacturing projects, developing commercial activities and establishing your presence in the Japanese market by using soft landing facilities.

Agenda – EU-Japan matchmaking event

Your participation is free and no registration is required. For more information, please contact us:


2 Comments

USA Mission report

BioXclusters partners, along with some European SMEs, went to Boston (Massachusetts) last October 2013. Read the report we have produced with the description of the visits and information about the life sciences market.

The objective of the mission in Boston was to discover and detect key entry points of the biotech and medtech market in the USA and collaboration opportunities with the different organizations visited. The USA represents a key market in life sciences, and notably for Personalized Healthcare. With a life sciences sector weighting $61 billion and counting about 1.455 companies, among which 300 quoted in stock exchange, the USA is without any doubt the top-leading economy on this market.

The life sciences is indeed one of the most dynamic sector of the American economy were not less than $30 billion were invested for R&D in 2010. The American life sciences market alone accounts for 70% of the world turnover and for 15 % of the total sales of the biotechnologies market. Read more